← All trials
NCT07203118
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2025
- Primary completion
- Jun 30, 2027
- Completion date
- Feb 28, 2030
- First posted
- Oct 2, 2025
- Last posted
- Oct 2, 2025
- Enrollment
- 1444
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Xintong Pharmacy CompanyLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.